Cita APA

Ausín Herrero, P., Navarrete Rouco, M. E., Carazo, L., Sánchez-Trincado, J. L., Luzon, E., Nuevo, J., . . . Padilla-Galo, A. (2025). Early and sustained clinical benefits of benralizumab in severe eosinophilic asthma: Findings from the ORBE II study.

Citación estilo Chicago

Ausín Herrero, Pilar, Maria Eugenia Navarrete Rouco, Luis Carazo, José Luis Sánchez-Trincado, Elisa Luzon, Javier Nuevo, Mónica Santín, Jesús Sánchez, y Alicia Padilla-Galo. Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings From the ORBE II Study. 2025.

Cita MLA

Ausín Herrero, Pilar, et al. Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings From the ORBE II Study. 2025.